Literature DB >> 15467355

Methionine-enkephalin stimulates hydrogen peroxide and nitric oxide production in rat peritoneal macrophages: interaction of mu, delta and kappa opioid receptors.

Vesna Vujić1, Stanislava Stanojević, Mirjana Dimitrijević.   

Abstract

OBJECTIVE: Methionine-enkephalin (MET) modulates various functions of macrophages related to both immune and inflammatory reactions in a naloxone reversible manner, suggesting that opioid receptors are involved in the regulation of macrophage activity. Since an endogenous opioid ligand might interact with more than one type of opioid receptor, the receptor interaction determines its effect on a particular function.
METHODS: In the present study we have investigated the involvement of different opioid receptor types/subtypes in MET-induced modulation of H(2)O(2) and NO production in macrophages. Thioglycollate-elicited or resident rat peritoneal macrophages were treated in vitro with MET and/or specific antagonists of delta(1,2), delta(1), delta(2), mu and kappa opioid receptors.
RESULTS: MET increased H(2)O(2)production in phorbol myristate acetate-stimulated rat peritoneal macrophages mainly through delta(1) opioid receptor. MET also enhanced NO production in rat peritoneal macrophages stimulated with lipopolysaccharide through delta(1) and mu opioid receptors. The blockade of mu and kappa receptor facilitated a potentiating effect of MET on H(2)O(2) release, and blockade of kappa receptor further raised the MET-induced increase of NO production in macrophages.
CONCLUSION: It is concluded that both negative and positive functional interaction between delta, mu and kappa opioid receptors regulate the influence of MET on H(2)O(2) and NO production in rat peritoneal macrophages.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467355     DOI: 10.1159/000080150

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  6 in total

1.  Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs).

Authors:  Qiushi Wang; Xinghua Gao; Zhe Yuan; Zhe Wang; Yiming Meng; Yan Cao; Nicolas P Plotnikoff; Noreen Griffin; Fengping Shan
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial.

Authors:  Jill P Smith; Sandra I Bingaman; Francesca Ruggiero; David T Mauger; Aparna Mukherjee; Christopher O McGovern; Ian S Zagon
Journal:  Dig Dis Sci       Date:  2011-03-08       Impact factor: 3.199

3.  Comparison of stimulating effect on subpopulations of lymphocytes in human peripheral blood by methionine enkephalin with IL-2 and IFN-γ.

Authors:  Hui Hua; Changlong Lu; Weiwei Li; Jingjuan Meng; Danan Wang; Nicolas P Plotnikoff; Enhua Wang; Fengping Shan
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

4.  Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced Model of Experimental Rheumatoid Arthritis.

Authors:  Susan Hua; Thilani H Dias; Debbie-Gai Pepperall; Yuan Yang
Journal:  Front Pharmacol       Date:  2017-08-02       Impact factor: 5.810

5.  Inhibition of the growth of human melanoma cells by methionine enkephalin.

Authors:  Dong-Mei Wang; Guang-Chuan Wang; Jing Yang; Nicolas P Plotnikoff; Noreen Griffin; Yu-Man Han; Rui-Qun Qi; Xing-Hua Gao; Feng-Ping Shan
Journal:  Mol Med Rep       Date:  2016-11-14       Impact factor: 2.952

6.  Effects of leucine-enkephalin on catalase activity and hydrogen peroxide levels in the haemolymph of the Pacific Oyster (Crassostrea gigas).

Authors:  Dong-wu Liu; Zhi-wei Chen; Hong-zhi Xu
Journal:  Molecules       Date:  2008-04-15       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.